Download PDF

Other users also viewed these articles

The interrelation between anxiety and quality of life among patients with ulcerative colitis in remission Mario García-Alanis; Liz Toapanta-Yanchapaxi; Arturo Reyes-Velásquez; Fernando Mancilla; Isela Pérez-Mayo; Jesús K. Yamamoto-Furusho;
Gastroenterol Hepatol. 2023;46:747-53
Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection Alejandro Hernández Camba; Laura Ramos; María Blanca Madrid Álvarez; Lina Pérez-Méndez; Pilar Nos; Vicent Hernández; Ivan Guerra; Nuria Jiménez; Rufo Lorente; Mónica Sierra-Ausín; Daniel Ginard; Pilar Varela Trastoy; Laura Arranz; María José Cabello Tapia; Yamile Zabana; Manuel Barreiro-de Acosta;
Gastroenterol Hepatol. 2022;45:668-76
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study) Diego Casas Deza; Ana Belén Julián Gomara; Eva Caudevilla Biota; Belén Beltrán; Eugeni Domènech; Ana Gutiérrez Casbas; Miriam Mañosa; Yamile Zabana; Lourdes Roc Alfaro; Emilio Valverde Romero; Elena García González; Beatriz Sicilia; Viviana Laredo; Maria José Alcalá Escriche; Lucia Madero Velázquez; Rocío Ferreiro-Iglesias; Antonia Palmero Pérez; Margalida Calafat; Saioa Rubio Iturria; Irene Moraleja Yudego; Yolanda Ber Nieto; Sandra García Mateo; Javier P. Gisbert; Raquel Vicente Lidón; Lara Arias; Erika Alfambra; Ana Belén Doñate Borao; Elena Peña González; Pilar Corsino Roche; Miren Vicuña Arregui; Ainara Elorza; Manuel Domínguez Cajal; María Chaparro; Manuel Barreiro-de Acosta; Santiago García-López;
Gastroenterol Hepatol. 2024;47:821-33